Xylaria species presented a biotechnological potential and production of different active compounds which might be promising against anthracnose disease.
Introduction
Anthracnose is one of the most serious plant diseases affecting different cultures worldwide. This disease is usually caused by filamentous fungi in the genus Colletotrichum or Gloeosporium, and these pathogens cause great losses and hence reduction in the quality and quantity of fruits and vegetables. [1] [2] [3] [4] Anthracnose is considered the main disease of guarana (Paullinia cupana 'sorbilis' Mart., Sapindaceae). The pathogen infects leaves and stems, causing deformation and necrotic lesions. 5, 6 The current forms of control include the use of resistant cultivars, sanitary pruning and fungicides. 7 However, even with the use of some methods of controlling these cultures, they are not are free of anthracnose. Additionally, excessive application of fungicides increases the resistance of pathogens to agrochemicals and cause harm to human health and the environment. 8 Therefore, the search for natural products with antifungal activity of agronomic relevance is an important alternative for the control of diseases such as anthracnose. 9 In the search for bioactive compounds, only a small fraction of the estimated fungal biodiversity has been chemically investigated, 10 and only a small number of these have already been cultured and selected for drug production. 11, 12 Fungi have special interest because they are known to produce several secondary metabolites with a wide range of applications. 13 The fungi of the genus Xylaria stand out in the production of secondary metabolites, mainly of the class of cytochalasins, isocumarins, lactones, sesquiterpenos, triterpenos and xanthones, and with the most diverse biological activities, such as anticancer, antioxidant, antimicrobial, antiinflammatory, antiviral, inhibiting HIV-1 protease, antibiotic and antitumor, 14, 15 among others.
In a previous study, a screening was done with the fractions of 16 endophytic fungi isolated from Guarana plant from Amazonia, and two Xylaria spp. were selected because its activity against the phytopathogen Colletotrichum gloeosporioides. Thus, this research aimed to evaluate the antifungal potential of secondary metabolites produced by this two endophytic Xylaria spp. isolated from guarana (P. cupana).
Experimental

General procedures
Optical rotations were taken on a Polartronic H Schmidt & Haensch digital polarimeter (1 dm cell) at 23 • C. The 1 H nuclear magnetic resonance (NMR) was recorded on a Bruker 14.1 Tesla, AVANCE III model spectrometer (operating at 600.13 MHz for hydrogen frequency) with crioprobe TM . The chemical shifts are given on a ı (ppm) scale and referenced to tetramethylsilane (TMS). High-resolution electrospray ionization mass spectrometry (HR-ESI MS) was acquired by direct infusion on a Q-TOF Maxis Impact in the following conditions: capillary voltage, 4.50 kV; operating in electrospray positive mode; The ion source was set to a nebulizer pressure of 0.3 bar, a dry gas flow rate of 4 L min −1 , and a dry temperature of 180 • C; detection range: 100-700 Da with total ion count extracting acquisition. Data acquisition was performed using a Bruker Compass Data Analysis 4.2.
High-performance liquid chromatography (HPLC) was conducted using a Agilent 1100 Series UV/Vis with a quaternary pump, coupled to a UV detector MWD (Multiple Wavelength Detector), using a reversed phase column C 18 (250 mm × 4.60 mm, 5 m; Phenomenex Kinetex), with a mobile phase H 2 O/MeOH (80:20, v/v), flow rate 1 mL min −1 and = 254 nm. HPLC-grade solvents were utilized. Solidphase extraction was carried out using silica gel cartridges of different dimensions (Phenomenex). Gel permeation chromatography was performed in a glass column filled with Sephadex LH-20 (Pharmacia). Silica gel 254 (Macherey-Nagel) were used for thin-layer chromatography (TLC). Spots were detected under UV light (254 and 365 nm).
Fungal isolation
The endophytic fungi (isolates 249 and 214) were isolated from leaves of guarana plant (P. cupana) with anthracnose symptoms (necrotic lesions), collected at Manaus-AM (03 • 22 5) , at the Experimental Farm of the Federal University of Amazonas (UFAM), and Maués-AM (57 • 42 0), at Fazenda Santa Helena (Ambev -American Beverage Company), in November 2010. The collected samples were leaves and branches of a total of 20 adult plants (10 of each locality). Complete intact leaves were rinsed with running water and then with distilled water. The cleaned leaves were sterilized by consecutive washes in 75% EtOH (1 min), 3% NaOCl (3 min) and 75% EtOH (30 s), and they were rinsed with sterile distilled H 2 O two times. 16, 17 The sterilized material was cut into 8 × 12 mm and 3-4 pieces were deposited on a Petri dish containing potato dextrose agar (PDA, Kasvi TM , Brazil), chloramphenicol and streptomycin (100 g mL −1 of each) to prevent bacterial growth. Plates were incubated at 27 • C. Petri dishes were observed daily, and the individual hypha tips of the emerging colonies were re-inoculated in new PDA plates until pure cultures were obtained. Pure cultures of the endophytes (isolates 249 and 214) were preserved by the Castellani method. 18 
Fungal identification
Pure culture of isolates 249 and 214 were first grown in malt agar 2% (in g L −1 : 20 malt extract, and 15 agar, Acumedia, Neogen TM ) at 25 • C for seven days. Then, fresh mycelia were harvested from and used for DNA extraction based on the CTAB method (cetyltrimethyl ammonium bromide) used in Montoya et al. 19 We amplified the ITS barcoding region using ITS4 and ITS5 primers. Amplicons were cleaned up and submitted to cycle-sequencing reactions using BigDye Terminator v. 3.1 Kit (Thermo Fischer Scientific). Bidirectional sequences were generated in ABI 3530 (Thermo Fischer Scientific) using the same primer pair.
Forward and reverse sequences were assembled in contigs in Bioedit. 20 Then, contigs were compared with homologous sequences deposited in the NCBI-Genbank.
To refine the taxonomic assignment of isolates 249 and 214, we carried out a phylogenetic analysis in MEGA v.6.0. 21 For this analysis, we retrieved sequences from closet relative taxa deposited in the database. Sequences were aligned in MAFFT, 22 and this dataset was used to infer a phylogenetic tree under the neighbor-joining algorithm and the Kimura 2-parameters as the nucleotide substitution model. Branch support was calculated using 1000 bootstrap pseudoreplicates.
Isolation of the active compounds
The endophytic fungi 249 and 214 were separately fermented in malt extract broth (in g L −1 : 20 malt extract, Kasvi TM , Brazil) at 27 • C under agitation (150 rpm) for five days (5 L; 20 mL × 250 mL batches in 500 mL Erlenmeyer flasks, for each fungal strain). The mycelium was separated from the liquid extract using vacuum filtration (filter Macherey Nagel TM , MN 640 m, 7 cm) and the liquid extract was extracted three times with EtOAc (100 mL of the liquid extract to 150 mL of EtOAc). Evaporation of the solvent from the extract in vacuo gave an EtOAc extract (306.4 mg for the strain 249 and 700.0 mg for the strain 214).
The EtOAc extract from the strain 249 was chromatographed on a Sep-Pak silica gel column (5 g, Waters TM ). The sample was solubilized in a mixture of hexane and CH 2 Cl 2 (100 L) and applied to the top of the column, which was eluting successively hexane/CH 2 Cl 2 /MeOH, starting with 100 mL of 100% hexane and increasing the gradient of CH 2 Cl 2 until 100% CH 2 Cl 2 , and then increasing the gradient of MeOH until 100%. Based on the TLC monitoring, all the fractions collected were combined in six main fractions (a-f). Bioactive fraction d (221.4 mg) was subjected to further CC fractionation over silica gel (5 g) eluted with hexane/CH 2 Cl 2 /MeOH to give five fractions (d1-d5). Bioactive fraction d1 (105 mg) was fractioned by gel filtration over Sephadex LH-20 column eluted with 100% MeOH to give five fractions (d1a-d1e), collected based on the retention time. Bioactive fraction d1b (44 mg) was purified on reverse phase HPLC using an isocratic elution H 2 O/MeOH (80:20) during 25 min to give four fractions (d1b1-d1b4), being the active d1b4 (retention time: 11.22 min) with 6.8 mg.
The EtOAc extract from the strain 214 was chromatographed on a Sep-Pak silica gel column (10 g, Waters ® )
eluting successively hexane/CH 2 Cl 2/ EtOAc/MeOH to give six fractions: 50 mL hexane: 50 mL CH 2 Cl 2 (fraction a), 100 mL CH 2 Cl 2 (fraction b), 50 mL CH 2 Cl 2 : 50 mL EtOAc (fraction c), 100 mL EtOAc (fraction d), 50 mL EtOAc: 50 mL MeOH (fraction e) and 100 mL MeOH (fraction f). Bioactive fraction d (375 mg), was subjected to further CC fractionation over silica gel (5 g) the same way described above to give six fractions (d1-d6). Bioactive fraction d3 (50 mL CH 2 Cl 2 : 50 mL EtOAc, 171 mg) was purified on reverse phase HPLC during 15 min using an isocratic elution H 2 O/MeOH (80:20) to give three fractions (d3a-d3c), being the active d3c with retention time 5.92 min (9.6 mg).
Antifungal bioassays
Disk-diffusion assay
The disk-diffusion assay (paper disk method) 23 was used to determine the antifungal activity during the separation and purification procedures. Each fraction obtained from different chromatographs was solubilized in MeOH and applied (10 L) to 6 mm diameter sterile paper disks (with 2 mg of each EtOAc extract, 1 mg of each fraction or 0.5 mg of each pure compound) and placed at one edge of the 60 mm PDA Petri dish plate (Kasvi TM , Brazil). An inoculum of the pathogen (a 7 mm diameter disc removed from a new peaked plate) was added to another edge of the PDA plate. The clear inhibition zones of mycelial growth around the paper disks were measured after incubation for 7 days at 27 • C. After this period, the inhibition percentages were calculated compared to the control using the analysis program Image J (Image Processing and Analysis in Java). This experiment was conducted with one repeat. For the negative control, 10 L of MeOH was applied in a sterile paper disk.
In order to know the fungicidal or fungistatic action of the isolated compounds, a small part of the fungi next to the paper disk with each compound was transferred to a new plate. The action was characterized by fungicide if the fungus does not grow in the new plate, and fungistatic if growth. Colletotrichum gloeosporioides used in this study was ceded by the UFAM, Amazonas-AM, Brazil. This phytopatogenic fungal strain was isolated from Guarana leaves infected with anthracnose and is deposited in the Central de Recursos Microbianos da UNESP (CRM-UNESP) under the code CRM 1352. An inoculum suspension of C. gloeosporioides spores was obtained from a 14 days-old culture and was added into liquid malt 2% medium (10 5 spores mL −1 , 60 L) to each well (final volume in the well = 100 L, completed with liquid malt 2% medium). Spores were obtained through the fungal culture on solid malt 2% medium after 14 days. The plate was scraped, and sterile distilled water was added. This solution was filtered in sterile glass wool to separate the spores, and the counting of the spores was done in Neubauer chamber. A growth control well (containing medium, inoculum, and the highest concentration of DMSO used in a CTW, but compound-free) was included. Microplates were incubated in B.O.D. at 28 • C and were read in a TECAN microplate reader, SUNRISE model, operated by the software Magellan v7.1, at 620 nm, in intervals of 12 h, for 144 h. The active ingredients of commercial fungicides Captan TM (N-(trichloromethylthio)ciclohex-4-ene-1,2-dicarboximide) and Score TM (difenoconazole, cis-trans-3-chloro-4-[4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl ether) were used as positive control in the same concentrations of the isolated compounds. The MICs were determined spectrophotometrically after the above mentioned incubation periods, according to the NCCLS guidelines, 24 with modifications. For commercial fungicides and compound, the MICs were determined as the lowest concentration showing absence or equal to the initial growth compared with the growth (until 12 h) in the drug-free well. 
Microdilution assays
Xylaria cubensis BCC 1144
Results
Isolation and identification of the endophytes
The strains 249 and 214 were isolated from the guarana leaves in the Amazon in two different places. After purification of the strains and based on the phylogenetic analysis, the sequences of isolates 249 and 214 clustered with sequences from other Xylaria species with high bootstrap support. Thus, here we tentatively identified these fungi as Xylaria sp. (Fig. 1) 
Bioguided isolation of the active compound
The EtOAc extract (306 mg) from the strain 249 showed 60.39% inhibition to C. gloeosporioides. This extract was fractionated by chromatography on a silica-gel column, permeation chromatography on Sephadex LH-20 gel and reverse phase HPLC. The active compound showed 51.33% activity (code d1b4, 6.8 mg).
The EtOAc extract (700 mg) from the strain 214 showed 30.76% inhibition to C. gloeosporioides. This extract was fractionated by chromatography on a silica-gel column and reverse phase HPLC. The active compound (code d3c, 9.6 mg) showed 38.76% inhibition to C. gloeosporioides. These compounds were identified by analysis of spectroscopic data (MS and NMR) and compared with compounds in the Dictionary of Natural Products database. 27 
Identification of the bioactive compounds
Compound d1b4
The compound d1b4 (6.8 mg) presents an UV max at 227.2 nm. In the high-resolution mass spectrum, molecular ions were observed at m/z 215. 1 H NMR spectrum, it was possible to correlate the hydrogens shifts (ı H ) of d1b4 with the compound piliformic acid. 26, 27 The experiment of optical rotation provided [˛] D 23 −0.0375 (c, 1 mg mL −1 in MeOH), allowing identify it as (−)-piliformic acid. Piliformic acid (Fig. 2-A) , exists in levo, dextro and racemic form, although the absolute stereochemistry has not been determined. 27 
Compound d3c
The compound d3c presents an UV max at 217 and 286 nm.
In the high-resolution mass spectrum, molecular ions were (Fig. 2-B) .
Evaluation of the active compounds
The isolated compounds piliformic acid and cytochalasin D have fungistatic activity against C. gloeosporioides. Piliformic acid inhibited 51.33% of the mycelial growth of C. gloeosporioides by the disk diffusion method, and cytochalasin D 38.76%, both in a concentration of 500 g disk −1 . In the microdilution assay (Fig. 3) all the compounds showed antifungal activity. Captan and difenoconazole were included as positive controls (MIC of 16.63 and 0.02 mol mL −1 , respectively). Piliformic acid and cytochalasin D were active against C. gloeosporioides, with a MIC of 2.92 and 2.46 mol mL −1 , respectively. Both have a higher MIC than the active ingredient difenoconazole, but a lower MIC than captan. Commercial fungicides were chosen because they are from different chemical classes and presented distinct mechanisms of action.
Discussion
The piliformic acid (CAS 98985-75-2), also known as 2-hexylidene-3-methylbutanedioic acid, 2-cyclohexylidene-3-methylsuccinic acid or 3-Nonene-2,3-dicarboxylic acid 25 belongs to the chemical class of the polyketides. 29 The biosynthesis of piliformic acid has been studied. The metabolite can be retro-biosynthetically cleaved to generate a C8 and a C3 moiety, and the C8 unit is derived directly from octanoate that originates from a fatty acid synthase (FAS) rather than from a polyketide synthase (PKS). 26 The synthesis was already studied by Mangaleswaran and Argade, 27 and it was an easy, four-step. Piliformic acid was identified the first time by Anderson et al. 30 as a metabolite produced by fungi of the family Xylariaceae: Hypoxylon (H. deustum), Poronia (P. piliformis) and Xylaria (X. polymorpha, X. longipes, X. Mali and X. hypoxylon). 26 This compound is commonly found in endophytic fungi belonging to the Xylariaceae, especially in the genus Xylaria. It was already isolated from the marine-derived fungus Xylaria sp. PSU-F100 31 and also from an endophytic Xylaria sp. of Pinus strobus. 32 This metabolite is also produced by others fungi, as several endophytic fungi isolated from the mangrove plant Avicennia marina 33 and from an endophytic Aspergillus allahabadii BCC45335 34 among others.
The cytochalasin D belongs to the chemical class of the N-containing compounds and was first reported by Aldridge and Turner, 35 isolated from the fungus Metarhizium anisopliae. Subsequently this compound was isolated from other fungi, such as Hypoxylon terricola 36 and Engleromyces goetzii. 37 There are over 60 known cytochalasins, wich were isolated from different genera of fungi, such as Phoma sp., Daldinia sp. Chalara sp., Hypoxylon spp., among others. The production of cytochalasin D has been reported by fungi in the genus Xylaria, as X. hypoxylon, 15 X. mellisii, 38 Xylaria sp., 39 X. carpophila, 40 X. cubensis, 41 X. arbuscula 42 and Xylaria sp. NC1214, a fungal endophyte of the moss Hypnum sp. 43 In our work, we discovered the fungistatic activity of piliformic acid and cytochalasin D against the plant pathogen C. gloeosporioides. Studies suggest that fungistatic agents are unable to inhibiting the morphogenetic transformation and are more likely to block growth by budding. 44 In literature, few biological activities have been related for the piliformic acid. This compound has moderate cytotoxicity against cancer cells KB e BC-1 45 and antifungal activity in yeast genera Nadsonia, Nematospora, Rhodotorula and Saccharomyces to a concentration >100 mg L −1 in tests performed by the disk diffusion method. 46 Piliformic acid also showed mild antibacterial activity against standard Staphylococcus aureus ATCC 25923 and methicillin-resistant strain. 47 The activity against the plant pathogens Cladosporium cladosporioides and C. sphaerospermum in bioautography assay (with 25 and 10 g mL −1 ) was also described. 48 The biological activities of cytochalasins include glucose transport, inhibition of the actin polymerization, secretion of hormones, immunosuppressive activity, antibiotic, antiviral, herbicidal and antifungal activity. [49] [50] [51] [52] [53] The activity of cytochalasin D against five tumor cell lines have been tested, and the IC 50 ranged from 0.22 to 1.44 M. 43 In agronomy, as an antifungal agent, cytochalasin D has activity against the plant pathogen Botrytis cinerea, the causal agent of gray mold on plants, at a concentration of 25 g disc −1 , in a disk diffusion method bioassay. 49 The cytochalasin D was also tested against C. cladosporioides and C. sphaerospermum, the causal agents of verrucose in plants, by the by bioautography method. It inhibited the plant pathogens in a concentration of 10 and 25 g mL −1 , respectively. 51 In our study, cytochalasin D was active against C. gloeosporioides with a MIC of 2.46 mol mL −1 . In the literature, there are others compounds with activity against this plant pathogen, as preussomerin EG1 and its derivatives monoacetylpreussomerin and diacetylpreussomerin EG1, with MIC at 100 g mL −1 (0.28 mol mL −1 ) by dilution in agar (radial growth-inhibitory activity). 54 In another study, the compounds cyclotryprostatin A and tryptoquivaline O were tested against C. gloeosporioides by microdilution test and showed MIC of 50 g mL −1 (0.12 mol mL −1 ) and 100 g mL −1 (0.18 mol mL −1 ), respectively. 55 The compound dehydrozaluzanin exhibited activity at 30 mM. 56 The isolated compounds piliformic acid and cytochalasin D have MIC values of 2.92 and 2.46 mol mL −1 .
The mechanism of action of cytochalasin D involves its binding capacity to actin filaments and therefore prevents polymerization and elongation. Therefore affect cell morphology and inhibit cellular processes such as cell division, which becomes some cases apoptosis. 57 Moreover, cytochalasin D inhibits protein synthesis. 58 The isolated compounds acid piliformic and cytochalasin D we are founded to present promising antifungal activity against C. gloeosporioides (from guarana plant), which causes the anthracnose disease. These compounds were produced by endophytic Xylaria spp. (from Manaus and Maués), in the Amazonia Forest. Thus, it was possible to verify that both Xylaria species presented a biotechnological potential and production of different active compounds. The compounds isolated in the present work are here reported for the first time as antifungal agents against C. gloeosporioides, a relevant plant pathogen worldwide. However, toxicity tests and in vivo bioassays need to be performed.
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